These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28766862)

  • 1. Inhibition of Protein-Protein Interactions: New Options for Developing Drugs against Neglected Tropical Diseases.
    Berg T
    Angew Chem Int Ed Engl; 2017 Sep; 56(40):12048-12050. PubMed ID: 28766862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
    PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron-based drugs as antiprotozoals.
    Jacobs RT; Plattner JJ; Keenan M
    Curr Opin Infect Dis; 2011 Dec; 24(6):586-92. PubMed ID: 22001943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Drug Targets in the Pentose Phosphate Pathway of Trypanosomatids.
    Loureiro I; Faria J; Santarem N; Smith TK; Tavares J; Cordeiro-da-Silva A
    Curr Med Chem; 2018; 25(39):5239-5265. PubMed ID: 29210635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K
    Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeping sickness: PEX and drugs.
    Schliebs W
    Biochim Biophys Acta; 2006 Jan; 1763(1):4-5. PubMed ID: 16473137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting cysteine proteases in trypanosomatid disease drug discovery.
    Ferreira LG; Andricopulo AD
    Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 16. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
    Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
    Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.
    Herrera Acevedo C; Scotti L; Feitosa Alves M; Formiga Melo Diniz MF; Scotti MT
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
    Pone BK; Ferreira EI
    Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.